Results 61 to 70 of about 2,797 (93)

Predictive and prognostic factors of efficacy of third-line chemotherapy in patients with unresectable pancreatic cancer: a cohort-based study. [PDF]

Oncologist
Evrard C, Pelras A, Rivet S, Bachet JB, Dubreuil O, Pointet AL, Taieb J, Lahlou W, Portal A, Lepère C, Lecomte T, Chautard R, Williet N, Phelip JM, Coutzac C, Soularue E, Marthey L, Abdallah R, Thirot Bidault A, Artru P, Desrame J, Le Roy B, Jary M, Hammel P, Trouilloud I, Lourenco N, Hautefeuille V, Dahan L, Pernot S, Béchade D, Pozet A, Bonnetain F, Locher C, Dréanic J, Coriat R, Tchoundjeu B, Foucher Y, Tougeron D.   +37 more
europepmc   +1 more source

Real-World Outcomes of Atezolizumab-Bevacizumab in Hepatocellular Carcinoma: The Prospective French CHIEF Cohort. [PDF]

Liver Int
Allaire M, Thiam EM, Amaddeo G, Bouattour M, Edeline J, Brusset B, Ziol M, Merle P, Blanc JF, Uguen T, Ganne N, Cattan S, Riachi G, Loustaud-Ratti V, Decaens T, Silvain C, Peron JM, Baron A, Pageaux GP, Oberti F, Anty R, Pascale A, Manfredi S, Bourliere M, Nousbaum JB, Heurgue A, Ollivier-Hourmand I, Lequoy M, Bronowicki JP, Villing AL, Ducournau G, Ganry O, Costentin C, Nguyen-Khac E.   +33 more
europepmc   +1 more source

Sex Differences in Patient-Reported Outcomes Among People Living With HIV Switching to an Oral Dual Therapy: Results From the PROBI Study. [PDF]

AIDS Res Treat
Alain T, Marcellin F, Bessonneau P, Hocqueloux L, Muehlan H, Allavena C, Zucman D, Villalonga-Olives E, Chassany O, Duracinsky M.   +9 more
europepmc   +1 more source

Safety of baricitinib in vaccinated patients with severe and critical COVID-19 sub study of the randomised Bari-SolidAct trial. [PDF]

EBioMedicine
Viermyr HK, Tonby K, Ponzi E, Trouillet-Assant S, Poissy J, Arribas JR, Dyon-Tafani V, Bouscambert-Duchamp M, Assoumou L, Halvorsen B, Tekin NB, Diallo A, De Gastines L, Munthe LA, Murphy SL, Ueland T, Michelsen AE, Lund-Johansen F, Aukrust P, Mootien J, Dervieux B, Zerbib Y, Richard JC, Prével R, Malvy D, Timsit JF, Peiffer-Smadja N, Roux D, Piroth L, Ait-Oufella H, Vieira C, Dalgard O, Heggelund L, Müller KE, Møller JH, Kildal AB, Skogen V, Aballi S, Sjøberg Øgaard JD, Dyrhol-Riise AM, Tveita A, Alirezaylavasani A, Costagliola D, Yazdanpanah Y, Olsen IC, Dahl TB, Kared H, Holten AR, Trøseid M.   +48 more
europepmc   +1 more source

sST2 is a key outcome biomarker in COVID-19: insights from discovery randomized trial. [PDF]

Sci Rep
Smadja DM, Massonnaud CR, Philippe A, Rosa M, Luneau S, Rauch A, Peiffer-Smadja N, Gagneux-Brunon A, Poissy J, Gruest M, Ung A, Pourcher V, Raffi F, Piroth L, Bouiller K, Esperou H, Delmas C, Belhadi D, Diallo A, Saillard J, Dechanet A, Mercier N, Dupont A, Lescure FX, Goehringer F, Jaureguiberry S, Danion F, Tolsma V, Cabie A, Courjon J, Leroy S, Mootien J, Mourvillier B, Gallien S, Lanoix JP, Botelho-Nevers E, Wallet F, Richard JC, Reuter J, Gaymard A, Greil R, Martin-Blondel G, Andrejak C, Yazdanpanah Y, Burdet C, Diehl JL, Hites M, Ader F, Susen S, Mentré F, Dupont A, Discovery Study Group.   +51 more
europepmc   +1 more source

Addressing the Global Challenge of Nitrous Oxide Misuse Through a Multidisciplinary Approach: Example of the PROTOSIDE Network. [PDF]

Toxics
Grzych G, Diesnis R, Dupré T, Niguet JP, Gernez E, Denimal D, Deheul S, Guichard JC, Scliffet D, Mégarbane B, Redonnet-Vernhet I, Boucher A, Bennis A, Karila L, Cavalier E, Rolland B, Riou C, Bossaert C, Chauvin A, multidisciplinary network PROTOSIDE.   +19 more
europepmc   +1 more source

Substance use disorder of equimolar oxygen-nitrous oxide mixture in French sickle-cell patients: results of the PHEDRE study. [PDF]

Orphanet J Rare Dis
Gérardin M, Rousselet M, Couec ML, Masseau A, PHEDRE Group, Aquizerate A, Authier N, Deheul S, Roussin A, Micallef J, Djezzar S, French Addictovigilance Network (FAN), Feuillet F, Jolliet P, Grall-Bronnec M, Victorri-Vigneau C.   +15 more
europepmc   +1 more source

Gut microbial dysbiosis associated to diarrheic irritable bowel syndrome can be efficiently simulated in the Mucosal ARtificial COLon (M-ARCOL). [PDF]

Bioengineered
Uriot O, Deschamps C, Scanzi J, Brun M, Kerckhove N, Dualé C, Fournier E, Durif C, Denis S, Dapoigny M, Langella P, Alric M, Etienne-Mesmin L, Stéphanie BD.   +13 more
europepmc   +1 more source

Prognostic value of disease severity and mechanical ventilation intensity in acute respiratory distress syndrome: analysis of the LUNG SAFE cohort. [PDF]

Eur Respir J
Rezoagli E, Laffey JG, Madotto F, Protti A, Pham T, Pesenti A, Bellani G, Brochard L, LUNG SAFE Investigators and the ESICM Trials Group.   +8 more
europepmc   +1 more source

Impaired serum neutralization and death in Omicron-infected critically ill patients: insights from the French SEVARVIR prospective, multicenter cohort study. [PDF]

Intensive Care Med Exp
Bruel T, Staropoli I, Bay P, Bastard P, Préau S, Guigon A, Guillon A, Stefic K, Uhel F, Pelleau S, Garcia L, Puel A, Cobat A, Casanova JL, Pawlotsky JM, White M, Schwartz O, Fourati S, de Prost N.   +18 more
europepmc   +1 more source